KMPHARMACEUTICAL Proposes Charter and Compensation Rule Changes; Related Party Loan Risks Under Spotlight


  • KMPHARMACEUTICAL will hold an extraordinary general meeting on June 23, 2026 to vote on three agenda items: partial amendment of articles of incorporation, establishment of executive compensation rules, and revision of retirement pay rules.
  • The company has adopted an electronic voting system to enhance shareholder convenience, and notice to minority shareholders is replaced by this public announcement.
  • Outstanding loans to a related party, Seokjeong Golf & Resort Co., Ltd., amount to 10.4 billion KRW, representing approximately 90% of the current market capitalization, raising concerns about financial soundness.
  • While the company is pursuing new businesses such as pet care and bottled water, additional facility investments are on hold, and profitability improvement remains a challenge amid domestic market contraction and intensified competition.
  • [AI Summary]This EGM involves procedural governance items with limited direct impact on shareholder value; however, the excessive related-party loans and depressed stock price warrant a neutral assessment with emphasis on risk management.

KOSDAQ Filing Information


  • Notice of Convocation of Shareholders' Meeting
  • Company: KMPHARMACEUTICAL (225430)
  • Submission: KMPHARMACEUTICAL Co.,Ltd.

  • Shares: 5,577,410
  • Price: 2,060 KRW
  • Market Cap: 11.5 B KRW